Skip to main content
SpringerLink
Log in

Nonoperative Treatment of Renal Cell Carcinoma

  • Chapter
Renal and Adrenal Tumors

  • 122 Accesses

Abstract

Nonoperative treatment of hypernephroma comprises irradiation and transfemoral catheter embolization of advanced, inoperable, and symptomatic primary tumors; as well as chemotherapy for metastases, using cytostatic substances, hormones, and immunotherapeutic agents.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Abbatucci J-S, Quint R, Bloquel J, Roussel A, Urbajtel M (1976) Techniken der kurativen Telekobalttherapie. Enke Stuttgart

    Google Scholar 

  2. Andersson L, Edsmyr F (1982) Pre- and postoperative radiotherapy, influence on prognosis. Prog Clin Biol Res 100: 609

    PubMed  CAS  Google Scholar 

  3. Andreew A, Ranft R, Templin R (1971) Auswertung von 75 Patienten mit einem hypernephroiden Nierenkarzinom. Zentralbl Chir 43: 1487

    Google Scholar 

  4. Arner O, Blanck C, von Schreeb T (1965) Renal adenocarcinoma: morphology — grading of malignancy — prognosis. Acta Chir Scand 346 (Suppl): 1

    CAS  Google Scholar 

  5. Baisch H (1984) Flußzytometrische Untersuchungen des DNA-Gehaltes und der Proliferationskinetik menschlicher Tumoren. Strahlentherapie 160: 431

    PubMed  CAS  Google Scholar 

  6. Bennington JL, Kradjian RM (1967) Renal carcinoma. Saunders, Philadelphia

    Google Scholar 

  7. Bischoff W, Sommerkamp H (1977) Zur Problematik der operativen Therapie maligner Nierentumoren. Schweiz Med Wochenschr 107: 699

    PubMed  CAS  Google Scholar 

  8. Bloom HJG, Baker WH, Duke CE, Mitchley BC (1963) Hormone dependent tumors of the kidney. II. Effect of endocrine ablation procedure on the transplanted estrogen-induced renal tumors of the Syrian hamster. Br J Cancer 17: 646

    Article  PubMed  CAS  Google Scholar 

  9. Bloom HJG, Roe F, Mitchley B (1967) Sex hormones and renal neoplasia. Inhibition of tumor of hamster-kidney by an estrogen antagonist. An agent of possible therapeutic value in man. Cancer 20: 2118

    Article  PubMed  CAS  Google Scholar 

  10. Bloom HJG, Wallace DM (1971) Tumors of the urinary tract. In: Zuppinger A, Krokowski E (eds) Handbuch der medizinischen Radiologic. Spezielle Strahlentherapie maligner Tumoren, vol 19, part 3. Springer, Berlin Heidelberg New York, p. 399

    Google Scholar 

  11. Bodey CP (1979) Current status of chemotherapy in metastatic renal carcinoma. In: Johnson DE, Samuels MC (eds) Cancer of the genitourinary tract. Raven, New York

    Google Scholar 

  12. Boeminghaus F, Greipel V, Schwartmann KP (1982) Analyse der Langzeitergebnisse nach Nephrektomie wegen Hypernephrom anhand von 442 Fällen. Urologe A 21: 201

    PubMed  CAS  Google Scholar 

  13. Bostel F, Kuhne-Velte HJ, Wöllgens P (1983) Wertigkeit der Strahlentherapie bei Metastasen des hypernephroiden Karzinoms. Strahlentherapie 159: 404

    PubMed  CAS  Google Scholar 

  14. Bostel F, Kuhne-Velte HJ, Wöllgens P (1984) 12 Jahre Überlebenszeit eines Patienten mit metastasiertem Hypernephrom unter palliativer Schmerztherapie. Akt Urol 15: 88

    Article  Google Scholar 

  15. Boxer RJ, Waisman J, Lieber MM, Mampaso FM, Skinner DG (1979) Renal carcinoma: computer analysis of 96 patients treated by nephrectomy. J Urol 122: 598

    PubMed  CAS  Google Scholar 

  16. Bratherton DG (1964) Tumours of the kidneys and suprarenals. III. The place of radiotherapy in the treatment of hypernephroma. Br J Radiol 37: 141

    Article  PubMed  CAS  Google Scholar 

  17. Brosig W, Baumgärtel H, Oeser H (1971) Die präoperative Bestrahlung der Nierentumoren aus chirurgischurologischer Sicht. In: Hug O (ed) Präoperative Tumorbestrahlung. Vorträge vom Deutschen Röntgenkongreß 1970. Sonderbande zur Strahlentherapie, vol 71. Urban and Schwarzenberg, München, p 84

    Google Scholar 

  18. Brühl P, Scheef W, Albert H, Bücheler E (1975) Therapie und Prognose des hypernephroiden Nierenkarzinoms. Med Klin 70: 873

    PubMed  Google Scholar 

  19. Brühl P, Vahlensieck W, Höfer-Janker H, Scheef W, Thelen M (1976) Das hypernephroide Nierenkarzinom. Aktuel Nephrol 1: 97

    Google Scholar 

  20. Buschke F, Parker RG (1972) Radiation therapy in cancer management. Grune and Stratton, New York

    Google Scholar 

  21. Callahan SK, Knight WA, Murphy A (1981) A phase II trial of methyl-glyoxal bisguanylhydrazone (MGBG, methyl GAG) in renal carcinoma. Proc Am Assoc Cancer Res Am Soc Clin Oncol, (Abstract 649) 22: 164

    Google Scholar 

  22. Carl P, Rabes H, Eisenberger F, Schmidt P (1974) Autoradiographische Untersuchungen zur DNS-Synthese bestrahlter und nichtbestrahlter Nierenkarzinome bei normothermer Perfusion. Verh Dtsch Ges Urol, 26. Tagung. Springer, Berlin Heidelberg New York, p 176

    Google Scholar 

  23. Cavanaugh PJ (1967) Adjunctive radiotherapy in renal carcinoma of adults. In: King JS (ed) Renal neoplasia. Little and Brown, Boston, p 559

    Google Scholar 

  24. Cinqualbre J, Goldschmidt P, Bollack C (1982) Le can cer du rein. A propos d’une serie de 230 cas. Sem Hop Paris 58: 812

    PubMed  CAS  Google Scholar 

  25. Day JW, Shrivastav S, Lin G, Bonar RA, Paulson DF (1981) In vitro chemotherapeutic testing of urologic tumors. J Urol 125: 490

    PubMed  CAS  Google Scholar 

  26. Egger B, Hartung R, Pollak E (1979) Staging und therapeutische Ergebnisse bei 288 hyper-nephroiden Nierenkarzinomen. Med Welt 30: 920

    PubMed  CAS  Google Scholar 

  27. Finney R (1973) The value of radiotherapy in the treatment of hypernephroma — a clinical trial. Br J Urol 45: 258

    Article  PubMed  CAS  Google Scholar 

  28. Finney R (1973) An evaluation of postoperative radio-therapy in hypernephroma treatment — a clinical trial. Cancer 32: 1332

    Article  Google Scholar 

  29. Firusian N (1978) Endoossale Isotopentherapie maligner Skeletterkrankungen. Z Krebsforsch 91: 143

    Article  CAS  Google Scholar 

  30. Flamm J, Wober L (1981) Der maligne Nierentumor. Wien Med Wochenschr 23 /24: 579

    Google Scholar 

  31. Flocks RH, Kadesky MC (1958) Malignant neoplasms of the kidney: an analysis of 353 patients followed five years or more. J Urol 79: 196

    PubMed  CAS  Google Scholar 

  32. Fossa SD, Kjolseth I, Lund G (1982) Radiotherapy of metastases from renal cancer. Eur Urol 8: 340

    PubMed  CAS  Google Scholar 

  33. Freed SZ, Halperin JP, Gordon M (1977) Idiopathic regression of metastases from renal cell carcinoma. J Urol 118: 538

    PubMed  CAS  Google Scholar 

  34. Fuhrmann SA, Lasky LL, Limas L (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6 (7): 655

    Article  Google Scholar 

  35. Fuselier HA, Guice SL, Brannan W, Ochsner MG, Sangisetty KV, Beckman EN, Barnes CA (1983) Renal cell carcinoma: the Ochsner Medical Institution experience (1945-1978). J Urol 130: 445

    PubMed  Google Scholar 

  36. Garnick MB (1981) Advanced renal cell cancer (nephrology forum). Kidney Int 20: 127

    Article  Google Scholar 

  37. Gauwerky F, Adam K (1971) Die Rolle der Radiotherapie bei der Behandlung der malignen Nierentumoren Erwachsener. Strahlentherapie 142: 629

    PubMed  CAS  Google Scholar 

  38. Gauwerky F (1973) Strahlenhandlung von Nierentumoren Erwachsener. Dtsch Aerztebl 70: 275

    Google Scholar 

  39. Giuliani L, Martorana G, Giberti C, Pescatore D, Magnani G (1983) Results of radical nephrectomy with extensive lymphadenectomy for renal cell carcinoma. J Urol 129: 664

    Google Scholar 

  40. Grawitz PA (1883) Die sogenannten Lipome der Niere. Arch Pathol Anat 93: 39

    Article  Google Scholar 

  41. Halperin EC, Harisiadis L (1983) The role of radiation therapy in the management of metastatic renal cell carcinoma. Cancer 51: 614

    Article  PubMed  CAS  Google Scholar 

  42. Hermanek P, Sigel A, Chlepas S (1976) Histological grading of renal cell carcinoma. Eur Urol 2: 189

    PubMed  CAS  Google Scholar 

  43. Herrlinger A, Sigel A, Schrott KM (1982) Die Bedeutung der lymphogenen Metastasierung des Nierencar- cinoms fur das Vorgehen bei der radikalen Tumorneph- rektomie. Verh Dtsch Ges Urol 34. Tagung. Springer, Berlin Heidelberg New York, p 104

    Google Scholar 

  44. Herrlinger A, Sigel A, Giedl J (1984) Methodik der radikalen transabdominalen Tumornephrektomie mit fakultativer oder systematischer Lymphdissektion und deren Ergebnisse an 381 Patienten. Urologe A 23: 267

    PubMed  CAS  Google Scholar 

  45. Higer HP (1981) Risikofaktoren für Folgeerkrankungen der Hypernephromtherapie. Strahlentherapie 157: 633

    PubMed  CAS  Google Scholar 

  46. von Hoff DD, Casper J, Bradley E, Sandbach J, Makuch R (1981) Association between human tumor colony-forming assay results and response in individual patient’s tumor to chemotherapy. Am J Med 70: 1027

    Article  Google Scholar 

  47. Hohenberg G (1983) Postoperative Radiotherapie beim hypernephroiden Karzinom — Auswertung von 63 Fallen. Urologe B 23: 323

    Google Scholar 

  48. Hop WCJ, van der Werf-Messing BHP (1980) Prognostic indexes for renal cell carcinoma. Eur J Cancer 16: 833

    PubMed  CAS  Google Scholar 

  49. Hrushesky WJ, Murphy GP (1974) Evaluation of chemotherapeutic agents in a new murine carcinoma model. J Natl Cancer Inst 52: 1117

    PubMed  CAS  Google Scholar 

  50. Hrushesky WJ, Murphy GP (1977) Current status of the therapy of advanced renal carcinoma. J Surg Oncol 9: 277

    Article  PubMed  CAS  Google Scholar 

  51. Huber H, Husslein P, Michalica W, Wagenbichler P (1984) Radiosensitizing effect of medroxyprogesterone acetate on endometrial cancer cells in vitro. Cancer 54: 999

    Article  PubMed  CAS  Google Scholar 

  52. Hudgins PT, Collins VP (1966) Radiotherapy for renal adenocarcinoma. Am J Roentgenol 96: 620

    CAS  Google Scholar 

  53. Hübener K-H, Eibach E (1977) Strahlentherapie des Nierenkarzinoms — Untersuchungen und Ergebnisse. Strahlentherapie 153: 726

    PubMed  Google Scholar 

  54. Hübener K-H, Junker A (1979) Vergleichende Bestrahlungsplanung mit konventioneller röntgendiagnostischer und computertomographischer Technik bei Nieren- und Harnblasenkarzinomen. Strahlentherapie 155: 376

    PubMed  Google Scholar 

  55. Hug O (1971) Strahlenbiologische Begründung, Methoden und Aussichten einer praoperativen Tumorbestrahlung. Zusammenfassung und Schlußwort. In: Hug O (ed) Präoperative Tumorbestrahlung. Vorträge vom Deutschen Rontgenkongreß 1970. Sonderbaende zur Strahlentherapie, vol 71. Urban and Schwarzenberg, München, p 115

    Google Scholar 

  56. Ishmael DR, Burpo LJ, Bottomley RH (1978) Combined therapy of advanced hypernephroma with medroxy-progesterone, BCG, adriamycin and vincristine. Abstract Proc Amer Soc Clin Oncol 19: 407

    Google Scholar 

  57. Javadpour N (1984) Surgical management of renal cancer. In: Javadpour N (ed) Cancer of the kidney. Thieme-Stratton, New York, p 69

    Google Scholar 

  58. Jones GW (1982) Renal cell carcinoma. CA 32: 280

    PubMed  CAS  Google Scholar 

  59. Juusela H, Malmio K, Alfthan O, Oravisto KJ (1977) Preoperative irradiation in the treatment of renal adenocarcinoma. Scand J Urol Nephrol 11: 277

    Article  PubMed  CAS  Google Scholar 

  60. Juusela H (1978) Renal adenocarcinoma: clinical features and factors correlating to survival in 173 patients. Ann Chir Gynaecol Fenniae 67 suppl 193: 1

    Google Scholar 

  61. Kantor AF (1977) Current concepts in the epidemiology and etiology of primary renal cell carcinoma. J Urol 117: 415

    PubMed  CAS  Google Scholar 

  62. Katakkar SB, Franks CR (1978) Chemo-hormonal therapy for metastatic renal cell carcinoma with adriamycin, hydroxyurea, vinblastine and medroxy-progesterone acetate. Cancer Treat Rep 62: 1379

    PubMed  CAS  Google Scholar 

  63. de Kernion JB, Berry D (1980) The diagnosis and treatment of renal cell carcinoma. Cancer 45: 1947

    Google Scholar 

  64. de Kernion JB (1983) Treatment of advanced renal cell carcinoma — traditional methods and innovative ap-proaches. J Urol 130: 2

    Google Scholar 

  65. Knight WA, Livingston RB, Fabian C, Costanzi J (1979) Methyl-gloxal bisguanylhydrazone (methyl GAG, MGBG) in advanced human malignancy. Proc Amer Ass Cancer Res Amer Soc Clin Oncol (Abstract C-115) 20: 319

    Google Scholar 

  66. Kob D, Arndt J, Klötzer K-H, Stecher M, Kriester A (1974) Ergebnisse der Therapie von bösartigen Nierentumoren mit der ultraharten Bremsstrahlung eines 30-MeV-Betatron. Radiobiol Radiother (Berl) 15: 669

    Google Scholar 

  67. Kob D, Klötzer K-H, Arndt J, Stadie G (1980) Klinische Untersuchungen zum Problem der Vor- und Nachbestrahlung maligner Nierentumoren. Radiobiol Radiother (Berl) 21: 729

    CAS  Google Scholar 

  68. König HJ, Hartwich G (1980) Zytostatische Therapie des hypernephroiden Nierenkarzinoms. Dtsch Med Wochenschr 105: 1810

    Article  PubMed  Google Scholar 

  69. Kurth KH, van der Werf-Messing B, Maksimovic PA (1983) Nierenkarzinom: Lokale Radiotherapie von Metastasen in der Wirbelsäule. Verh Dtsch Ges Urol 34. Tagung. Springer, Berlin Heidelberg New York, p 64

    Google Scholar 

  70. Lack EE, Cassady JR, Sallan SE (1985) Renal cell carcinoma in childhood and adolescence: a clinical and pathological study of 17 cases. J Urol 133: 822

    PubMed  CAS  Google Scholar 

  71. Lieber MM, Tomera FM, Taylor WF, Farrow GM (1981) Renal adenocarcinoma in young adults: survival and variables affecting prognosis. J Urol 125: 164

    PubMed  CAS  Google Scholar 

  72. Lieber MM, Kovach JS (1981) Soft agar clonogenic assay for primary human renal cell carcinoma: in vitro chemotherapeutic drug-sensitivity testing. Invest Urol 19: 111

    PubMed  CAS  Google Scholar 

  73. von Lieven H, Lissner J (1977) Strahlentherapie beim Adenokarzinom der Niere. Strahlentherapie 153: 245

    Google Scholar 

  74. von Lieven H, Trott K-R, Sintermann R (1978) Experimentelle Ergebnisse der praoperativen Bestrahlung des renalen Adenokarzinoms. Strahlentherapie 154: 299

    Google Scholar 

  75. von Lieven H, Meister P, Keiditsch E (1978) Die Bedeutung des Differenzierungsgrades beim Adenokarcinom der Niere. MMW 120: 729

    Google Scholar 

  76. Lindner H (1981) Bestrahlungsplanung beim Nierenkarzinom. In: Schmiedt E, Bauer H-W (ed) Diagnostik und Therapie des Nierenkarzinoms. Zuckschwerdt, München, p 166

    Google Scholar 

  77. Lissner J (1974) Strahlentherapie bei Nierentumoren. Verh Dtsch Ges Urol 26. Tagung. Springer, Berlin Heidelberg New York, p 150

    Google Scholar 

  78. Ljungberg B, Stenling R, Roos G (1985) DNA content in renal cell carcinoma with reference to tumor hetero-geneity. Cancer 56: 503

    Article  PubMed  CAS  Google Scholar 

  79. Maentylae M, Nordman E, Minkkinen J (1977) Post-operative radiotherapy of renal adenocarcinoma. Ann Clin Res 9: 252

    Google Scholar 

  80. Mau S, Rießbeck K-H, Mandel L, Coblenz R (1980) Ergebnisse der Kombinationstherapie maligner Nieren-tumoren. Radiobiol Radiother (Berl) 21: 271

    CAS  Google Scholar 

  81. McDonald MW (1982) Current therapy for renal cell carcinoma. J Urol 127: 211

    PubMed  CAS  Google Scholar 

  82. McDonald MW, Diokno AC, Seski JC, Menon KM (1983) Measurement of progesterone receptor in human renal cell carcinoma and normal renal tissue. J Surg Oncol 22: 164

    Article  PubMed  CAS  Google Scholar 

  83. McNichols DW, Segura JW, DeWeerd JH (1981) Renal cell carcinoma: long-term survival and late recurrence. J Urol 126: 17

    PubMed  CAS  Google Scholar 

  84. Meister P (1981) Nierenkarzinom: Pathologische Anatomie. In: Schmiedt E, Bauer H-W (ed) Diagnostik und Therapie des Nierenkarzinoms. Zuckschwerdt, Muenchen, p 1

    Google Scholar 

  85. Murphy GP, Schirmer HK (1963) The diagnosis and treatment of hypernephroma. Geriatrics 18: 354

    PubMed  CAS  Google Scholar 

  86. Murphy GP, Mostofi FK (1965) The significance of cytoplasmic granularity in the prognosis of renal cell carcinoma. J Urol 94: 48

    PubMed  CAS  Google Scholar 

  87. Nakano E, Tada Y, Fujioka H, Matsuda M, Osafune M, Kotake T, Sato B, Takaha M, Sonoda T (1984) Hormone receptor in renal cell carcinoma and correlation with clinical response to endocrine therapy. J Urol 132: 240

    PubMed  CAS  Google Scholar 

  88. Nickolisen R, Fallon B (1985) Locally recurrent hypernephroma treated by radiation therapy and embolisation. A report of two cases. Cancer 56: 1049

    Article  PubMed  CAS  Google Scholar 

  89. Noecker D, Hobrecker M (1976) Therapieplanung und Prognosebeurteilung bei bosartigen Nierengeschwuelsten. Strahlentherapie 152: 498

    Google Scholar 

  90. Nurmi MJ (1984) Prognostic factors in renal carcinoma. An evaluation of operative findings. Br J Urol 56: 270

    Article  PubMed  CAS  Google Scholar 

  91. Ochsner MG, Brannan W, Pond HS, Goodier EH (1973) Renal cell carcinoma: review of 26 years of experience at the Ochsner Clinic. J Urol 110: 643

    PubMed  CAS  Google Scholar 

  92. Olver IN, Leavitt RD (1984) Chemotherapy and immunotherapy of disseminated renal cancer. In: Javadpour N (ed) Cancer of the kidney. Thieme-Stratton, New York

    Google Scholar 

  93. Otto U, Baisch H, Huland H, Kloppel G (1984) Tumor cell deoxyribonucleic acid content and prognosis in human renal cell carcinoma. J Urol 132: 237

    PubMed  CAS  Google Scholar 

  94. Otto U, Huland H, Baisch H, Kloeppel G (1984) Transplantation of human renal cell carcinoma into NMRI NU NU mice. II. Evaluation of response to vinblastine sulfate monotherapy. J Urol 131: 134

    PubMed  CAS  Google Scholar 

  95. Paces V, Poleckova V, Zamecnik J (1978) Preoperative irradiation of renal cell carcinoma in adults (controlled clinical trial). Int Urol Nephrol 10 (2): 77

    Article  PubMed  CAS  Google Scholar 

  96. Palma LD, Kenney GM, Murphy GP (1970) Childhood renal carcinoma. Cancer 26: 1321

    Article  PubMed  CAS  Google Scholar 

  97. Parienty RA, Richard F, Pradel J, Vallancien G (1984) Local recurrence after nephrectomy for primary renal cancer: computerized tomography recognition. J Urol 132: 246

    PubMed  CAS  Google Scholar 

  98. Patel NP, Lavengood RW (1978) Renal cell carcinoma: natural history and results of treatment. J Urol 119: 722

    PubMed  CAS  Google Scholar 

  99. Paulson DF, Perez CA, Anderson T (1985) Cancer of the kidney and the ureter. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer, principles and practice of oncology. Lippincott, Philadelphia, p 732

    Google Scholar 

  100. Pearson J, Friedmann MA, Hoffman PG (1981) Hormone receptors in renal cell carcinoma. Their utility as predictors of response to endocrine therapy. Cancer Chemother Pharmacol 6: 151

    Article  PubMed  CAS  Google Scholar 

  101. Pizzocaro G, DiFronzo G, Piva L, Salvioni R, Ronchi E, Cappelleti V, Giongo A, Mastroberadino E, Cozzoli C, Dormia E, Minervini S, Zanollo A, Fontanella U, Giannoni R, Maggioni A, Lasio E (1983) Adjunctive medroxyprogesterone acetate to radical nephrectomy in category MO renal cell carcinoma. Eur Urol 9: 202

    PubMed  CAS  Google Scholar 

  102. Pontes JE (1983) Adjunctive treatment of renal cell carcinoma. Int Adv Surg Oncol 6: 309

    PubMed  CAS  Google Scholar 

  103. Possinger K, Hartenstein R, Ehrhart H (1981) Chemotherapie des Adenokarzinoms der Niere. In: Schmiedt E, Bauer H-W (eds) Diagnostik und Therapie des Nierenkarzinoms. Zuckschwerdt, Muenchen, p 183

    Google Scholar 

  104. Poster DS, Bruno S, Penta J, Pirna K, Vilk P, Macdonald J (1982) Current status of chemotherapy, hormonal therapy and immunotherapy in the treatment of renal cell carcinoma. Am J Clin Oncol 5: 53

    PubMed  CAS  Google Scholar 

  105. Prignitz J, Popp FA, Scholz H (1973) Zur Optimierung der Bestrahlungsplanung in der 60-Co-Tiefentherapie. Ãœberlegungen zur Einstelltechnik bei Nierenmalignomen. Strahlentherapie 145: 378

    PubMed  CAS  Google Scholar 

  106. Rabes HM, Carl P, Meister P, Rattenhuber KU (1979) Analysis of proliferative compartments in human tumors. Cancer 44: 799

    Article  PubMed  CAS  Google Scholar 

  107. Rabes HM (1981) Zellkinetik des Nierenkarzinoms. In: Schmiedt E, Bauer H-W (eds) Diagnostik und Therapie des Nierenkarzinoms. Zuckschwerdt, München, p 15

    Google Scholar 

  108. Rafla S (1970) Renal cell carcinoma. Natural history and results of treatment. Cancer 25: 26

    Article  PubMed  CAS  Google Scholar 

  109. Rafla S, Parikh K (1984) The role of adjuvant radio-therapy in management of renal cell carcinoma. In: Javadpour N (ed) Cancer of the kidney. Thieme-Stratton, New York

    Google Scholar 

  110. Rahn H, Keiner P, Pinsler G (1982) Bestrahlungstechniken zur postoperativen Bestrahlung des Nierenkarzinoms. Radiobiol Radiother (Berl) 23: 551

    CAS  Google Scholar 

  111. Rhomberg W (1983) Zur Klinik und Strahlensensibilitaet von Knochenmetastasen bei Nierenkarzinomen. Strahlentherapie 159: 610

    PubMed  CAS  Google Scholar 

  112. Riches EW (1966) The place of radiotherapy in the management of parenchymal carcinoma of the kidney. J Urol 95: 313

    PubMed  CAS  Google Scholar 

  113. Riches EW (1968) Cancer of the urogenital tract: kidney. Localized renal adenocarcinoma. The place of irradiation. JAMA 204: 230

    Article  PubMed  CAS  Google Scholar 

  114. Riches EW (1970) Preoperative irradiation of carcinoma of the kidney. In: Riches EW (ed) Modern trends in urology, vol 3. Butterworths, London, p 216

    Google Scholar 

  115. Richter E, Bohndorf W (1979) Behandlungsergebnisse bei hypernephroiden Karzinomen unter besonderer Berücksichtigung des Metastasenproblems. Strahlentherapie 155: 607

    PubMed  CAS  Google Scholar 

  116. Ringleb D, Rommel K (1963) Zur radiologischen Klinik der Nierengeschwuelste Erwachsener. Strahlentherapie 121: 323

    Google Scholar 

  117. Ritchie AW, Kemp IW, Chisholm GD (1984) Is the incidence of renal carcinoma increasing? Br J Urol 56: 571

    Article  PubMed  CAS  Google Scholar 

  118. Robson CJ, Churchill BM, Anderson W (1969) The results of radical nephrectomy for renal cell carcinoma. J Urol 101: 297

    PubMed  CAS  Google Scholar 

  119. Robson CJ (1982) Results of radical thoraco-abdominal nephrectomy in the treatment of renal cell carcinoma. Prog Clin Biol Res 100: 481

    PubMed  CAS  Google Scholar 

  120. Rodriguez LH, Johnson DE (1978) Clinical trial of cisplatinum (NSC 119875) in metastatic renal cell carci-noma. Urology 11: 344

    Article  PubMed  CAS  Google Scholar 

  121. Röder K, Theuring F (1981) Strahlenbiologische Aspekte und morphologische Befunde nach Nierenvorbestrahlung. Radiobiol Radiother (Berl) 22: 609

    Google Scholar 

  122. Rohloff R, von Lieven H (1981) Die Rolle der Strahlentherapie bei der Behandlung des Adenokarzinoms der Niere. In: Schmiedt E, Bauer HW (ed) Diagnostik und Therapie des Nierenkarzinoms. Zuckschwerdt, München

    Google Scholar 

  123. Rost A, Brosig W, Ernst H (1976) Die preoperative Bestrahlung beim hyper-nephroiden Karzinom. Helv Chir Acta 43: 309

    PubMed  CAS  Google Scholar 

  124. Rübe W, Seegelken K (1974) Dickdarmstenosen nach Bestrahlung von Nierentumoren. Strahlentherapie 147: 63

    PubMed  Google Scholar 

  125. Saitoh H, Hida M, Nakamura K, Shimbo T, Shiramizu T, Satoh T (1982) Metastatic processes and a potential indication of treatment for metastatic lesions of renal adenocarcinoma. J Urol 128: 916

    PubMed  CAS  Google Scholar 

  126. Saksela E, Alfthan O, Malmio K (1973) Effect of pre-operative radiotherapy on the growth of human renal carcinoma tissue in vitro. Scand J Urol Nephrol 7: 181

    Article  PubMed  CAS  Google Scholar 

  127. Samuels ML, Sullivan P, Howe CD (1968) Medroxy-progesterone acetate in treatment of renal cell carcinoma (hypernephroma). Cancer 22: 525

    Article  PubMed  CAS  Google Scholar 

  128. Sarre H, Moser F (1961) Bestrahlungsfibrose, Bestrahlungsnephritis und isolierte Hypertonic nach Rontgen-bestrahlung der Niere. Dtsch Med J 12: 232

    PubMed  CAS  Google Scholar 

  129. Satomi Y, Takai S, Kondo J, Fukushima S, Furuhata A (1982) Postoperative prophylactic use of progesterone in renal cell carcinoma. J Urol 128: 919

    PubMed  CAS  Google Scholar 

  130. Scherer E (1980) Strahlentherapie, 2nd edn. Springer, Berlin Heidelberg New York

    Google Scholar 

  131. Schmidt CG (1976) Metastasierendes hypernephroides Nierenkarzinom. Dtsch Med Wochenschr 101: 347

    Google Scholar 

  132. Selli C, Hinshaw WM, Woodart BH, Paulson DF (1983) Stratification of risk factors in renal cell carcino-ma. Cancer 52: 899

    Article  PubMed  CAS  Google Scholar 

  133. Sigel A, Chlepas S, Hermanek P, Herrlinger A (1981) Stagnation in der Therapie der Nierentumoren — Chancen einer Besserung. In: Schmiedt E, Bauer HW (eds) Diagnostik und Therapie des Nierenkarzinoms. Zuckschwerdt, München, p 109

    Google Scholar 

  134. Skinner DG, Colvin RB, Vermillion CD, Pfister RC, Leadbetter WF (1971) The diagnosis and management of renal cell carcinoma. A clinical and pathologic study of 309 cases. Cancer 28: 1165

    Article  PubMed  CAS  Google Scholar 

  135. Skinner DG, Vermillion CD, Colvin RB (1972) The surgical management of renal cell carcinoma. J Urol 107: 705

    PubMed  CAS  Google Scholar 

  136. Smith RB, DeKernion JB, Ehrlich RM, Skinner DG, Kaufmann II (1984) Bilateral renal cell carcinoma and renal cell carcinoma in the solitary kidney. J Urol 132: 450

    PubMed  CAS  Google Scholar 

  137. Sparwasser C, Bach D, Sparwasser H, Altwein JE (1984) Das bilaterale Hypernephrom. Kritische Ubersicht und eigenes Therapiekonzept. Akt Urol 15: 312

    Article  Google Scholar 

  138. Standke E, Ölßner W, Melzer R (1984) CT-gestützte Bestrahlungsplanung der Nierentumoren. Radiobiol Radiother (Berl) 25: 361

    CAS  Google Scholar 

  139. Steinberg SM, Brodovsky HS, Goepp CE (1972) Renal carcinoma in mother and daughter. Cancer 29: 222

    Article  PubMed  CAS  Google Scholar 

  140. Stender HS, Berndt G (1968) Strahlenbehandlung von Tumoren der Nieren und des Nierenbeckens. Röntgenblatter 21: 69

    Google Scholar 

  141. Strietzel M, Ziegler P-G, Hamann D, Kittner KH, Hildebrandt K-H, Bast R (1984) Beitrag zur Strahlenbe-handlung maligner Nierentumoren. Radiobiol Radiother (Berl) 25: 383

    CAS  Google Scholar 

  142. Väth JM (1973) Cancer of the kidney - radiation therapy and its indications in non-Wilms’ tumors. Cancer 23: 1053

    Article  Google Scholar 

  143. Vergau W, Buerkle G, Herzer R, Sadowski P (1972) Dünndarmschädigung der Telekobalt-Pendelbestrahlung der Nierenregion. Strahlentherapie 144: 697

    PubMed  CAS  Google Scholar 

  144. Vermillion CD, Skinner DG, Pfister RC (1972) Bilateral renal cell carcinoma. J Urol 108: 219

    PubMed  CAS  Google Scholar 

  145. Voss AC, Wöllgens P, Klöckner D (1974) Das hyper-nephroide Karzinom. Methodik und Ergebnisse der postoperativen Radiotherapie bei 223 Patienten. Strahlentherapie 147: 447

    PubMed  CAS  Google Scholar 

  146. Wagle DG, Moore RH, Murphy GP (1975) Secondary carcinomas of the kidney. J Urol 114: 30–32

    PubMed  CAS  Google Scholar 

  147. Wagle DG, Seal DR (1970) Renal cell carcinoma — a review of 256 cases. J Surg Oncol 2: 23–32

    Article  PubMed  CAS  Google Scholar 

  148. Waters CA, Lewis LG, Frontz WA (1934) Radiation therapy of renal cortical neoplasms, with special reference to preoperative irradiation. South Med J 27: 290

    Article  Google Scholar 

  149. Waters WB, Richie IP (1979) Aggressive surgical approach to renal cell carcinoma. Review of 130 cases. J Urol 122: 306

    PubMed  CAS  Google Scholar 

  150. Wehbe S (1978) Duodenalstenosen nach Bestrahlung der Nierenregion wegen Malignom. Fortschr Geb Roentgenstr 129: 421

    Article  CAS  Google Scholar 

  151. Weissmüller J, Herrlinger A, von Maillot K (1983) Wert der Rezeptor-Bestimmung und der Hormontherapie beim metastasierenden Hypernephrom. Verh Dtsch Ges Urol, 34. Tagung. Springer, Berlin Heidelberg New York

    Google Scholar 

  152. van der Werf-Messing B (1973) Carcinoma of the kidney. Cancer 32: 1056

    Article  PubMed  Google Scholar 

  153. van der Werf-Messing B (1974) La place de la radio-therapie dans le traitement du cancer du rein et du cancer de la prostate chez l’adulte: Carcinome du rein. Un essai therapeutique. J Radiol Electrol 55: 785

    Google Scholar 

Download references

Authors
  1. R.-D. Müller
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Scherer
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. C. Wirtz
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Röntgendiagnostisches Zentralinstitut, Klinikum der Universität Essen, Hufelandstraße 55, D-4300, Essen, Germany

    Eberhard Löhr

  2. Institut für Pathologie, Klinikum der Universität Essen, Hufelandstraße 55, D-4300, Essen, Germany

    Lutz-Dietrich Leder

Rights and permissions

Reprints and permissions

Copyright information

© 1987 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Müller, RD., Scherer, E., Wirtz, C. (1987). Nonoperative Treatment of Renal Cell Carcinoma. In: Löhr, E., Leder, LD. (eds) Renal and Adrenal Tumors. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71207-4_11

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71207-4_11

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-71209-8

  • Online ISBN: 978-3-642-71207-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation